Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
6
×
boston top stories
life sciences
national
6
×
national blog main
national top stories
san francisco blog main
new york blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
biotech
cancer
celgene
deals
gene therapy
sanofi
biogen
biomarin pharmaceutical
car-t
crispr
drug prices
hemophilia
ipo
What
gene
6
×
bio
roundup
therapy
drug
aren’t
moves
patients
prices
science
advanced
alnylam’s
alzheimer’s
approval
becker
bff
billions
cancer
car
cas
cells
companies
conference
crispr
cutting
deals
defect
developers
devoted
different
disease
dollars
drive
drugs
easl
eaton
edge
edited
editing
experiments
Language
Current search:
national
×
" boston blog main "
×
gene
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”